Federal Register Watch: July 13, 2026 — FDA Moves to Rewrite Drug Manufacturing Registration Rules
A daily read of the Federal Register: an FDA drug-manufacturing overhaul, a $1 million DOE fraud-penalty ceiling, two FHFA housing-finance proposals, an OMB industry-classification revision, and a wave of China…
